Wet AMD is the leading cause of visual loss in people over the age of 50 in Europe and North America.
湿性老年黄斑变性amd是欧洲和北美超过了50岁的人们的视觉减退的首要原因。
Some are already used as cancer treatments and several are now in clinical trials for wet AMD, where they look promising.
有些已经用于癌症治疗，有几种正在进行湿性amd的临床试验，并且看起来很有希望成功。
Various forms of eye surgery and laser or light therapies are used to treat wet AMD, but these are either risky or of limited help.
多种眼科手术、激光或者光照疗法被用于治疗湿性amd，但是它们不是风险太高就是疗效有限。
In wet AMD, new blood vessels grow beneath the retina and leak blood and fluid, causing disruption and dysfunction of the retina and creating blind spots.
在湿性AMD中，新血管在视网膜下生长，渗漏的血液和液体造成视网膜破裂和失去功能，形成盲点。
The disease is wet age-related macular degeneration (wet AMD), in which blood vessels grow abnormally and leak into the centre of the retina, damaging sufferers' central vision.
患者一旦染上一种称之为年龄相关性黄斑变性(湿型amd)的疾病，其血管就会出现异常且会扩散到视网膜的中心，损害患者的中心视觉。
METHODS Observe the alteration fundus lesions of pre-treatment and post-treatment by fundus color photography, fundus fluorescein angiography (FFA) and OCT in the 78 eyes of 46 patients with wet AMD.
方法确诊为湿性AMD患者46例78只眼，观察治疗前后对患者的视力、眼底照相、荧光素眼底血管造影、OCT检查情况。
Progression to both dry and wet forms of advanced AMD disease was 25% less likely among those eating a diet rich in omega-3 fatty acids.
干性及湿性的中期老年性黄斑病变患者，饮食中含丰富奥米加- 3脂肪酸，均减低病情25%。
The two products are treatments for the "wet" form of age-related macular degeneration (AMD), which can rapidly lead to blindness (see main story).
两种药品都是用于治疗湿性amd的，湿性AMD可以迅速引起失明(见前)。
A new medicine in development for the wet form of AMD is a recombinant fusion protein that binds to the growth factor protein that plays a critical role in blood-vessel formation in the eye.
一种在研治疗湿性amd的新药是一种重组融合蛋白，它能结合眼内血管形成关键生长因子蛋白。
Objective To study specific image features of wet-form AMD using B scan ultrasonography.
目的研究湿性老年性黄斑变性（AMD）的B型超声特征。
Objective To study specific image features of wet-form AMD using B scan ultrasonography.
目的研究湿性老年性黄斑变性（AMD）的B型超声特征。
应用推荐